Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
RNA Polymerase II Transcription
100%
MNase
50%
Molecular Cell
50%
Signaling Pathway
50%
MicroRNA
50%
Janus Kinase 1 (JAK1)
50%
Glycoprotein 130 (gp130)
50%
Liver Cells
50%
Interleukin-6 Signaling
50%
TFIID
37%
Transcriptional Repressor
32%
Global Transcription
25%
Budding Yeast
25%
Signal Transducer
20%
Signaling Molecules
20%
Interleukin-6
20%
ChEC-seq
12%
GCN5
12%
Newly Synthesized RNA
12%
Nascent Transcription
12%
TATA-less Promoter
12%
Saccharomyces Cerevisiae
12%
Synergize
12%
Acetyltransferase
12%
Eukaryotes
12%
Dramatic Effect
12%
Gene Overlapping
12%
Transcription/transcription Factors
10%
Reporter Gene
10%
Therapeutic Implications
10%
Inhibitory Effect
10%
Signaling Cascades
10%
P-STAT3
10%
Surface Expression
10%
Target Gene Expression
10%
Targeted Therapy
10%
3′-untranslated Region (3′-UTR)
10%
Inflammatory Pathways
10%
Liver Cancer
10%
Combination Treatment
10%
Hyper-interleukin-6
10%
Inflammatory Diseases
10%
Screening System
10%
Protein Expression
10%
Novel microRNA
10%
Chronic Liver Disease
10%
Luciferase Activity
10%
Cellular Screening
10%
MiR-520h
10%
Systems-based
10%
Biochemistry, Genetics and Molecular Biology
Transcription
100%
RNA Polymerase II
100%
Promoter Region
50%
DNA Cleavage
25%
Budding Yeast
12%
Overlapping Gene
6%
Mediator
6%
Eukaryote
6%
RNA
6%
N-Acetyltransferase
6%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
50%
Glycoprotein
50%
Interleukin 6
50%
Luciferase
14%
Receptor
7%
Transcription Factors
7%
microRNA 16
7%
Inflammatory Disease
7%
Cytokine
7%
Chronic Liver Disease
7%
Malignant Neoplasm
7%
Janus Kinase 1
7%
Liver Cancer
7%
Diseases
7%
